Concomitant Statins and the Survival of Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Meta-Analysis

Statins are suggested to improve cancer survival by possible anti-inflammatory effect. However, it remains unclear if concomitant use of statins could improve the efficacy of immune checkpoint inhibitors (ICIs) in patients with non-small-cell lung cancer (NSCLC). Accordingly, a meta-analysis was per...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lei, Wang, Hong, Tian, Jizheng, Sui, Lili, Chen, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276478/
https://www.ncbi.nlm.nih.gov/pubmed/35855055
http://dx.doi.org/10.1155/2022/3429462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276478/
https://www.ncbi.nlm.nih.gov/pubmed/35855055
http://dx.doi.org/10.1155/2022/3429462

Ejemplares similares